Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study
- PMID: 26135923
- PMCID: PMC4489732
- DOI: 10.1371/journal.pone.0130598
Serum Human Chorionic Gonadotropin (β- hCG) Clearance Curves in Women with Successfully Expectantly Managed Tubal Ectopic Pregnancies: A Retrospective Cohort Study
Abstract
Objective: To establish clearance curves for serum β -hCG in women with successfully expectantly managed tubal ectopic pregnancies.
Design: Retrospective cohort study. Non- viable tubal ectopic pregnancy was diagnosed on transvaginal ultrasound. If initial serum β hCG was less than 5000 IU/L and patients were asymptomatic, expectant management was offered. Patients underwent serial β hCG measurements until serum β hCG was less than 20 IU/l, or the urine pregnancy test was negative.
Setting: Early Pregnancy and Gynaecology Assessment Unit, Kings College Hospital, London (December 1998 to July 2006).
Patients: We included 161 women with diagnosed non-viable tubal ectopic pregnancy who underwent successful expectant management.
Main outcome measure: Serum β hCG level.
Results: Mean initial serum β- hCG was 488 IU/L (41 - 4883) and median serum β hCG clearance time was 19 days (5 - 82). The average half-life of β hCG clearance was 82.5 hours (±SD 50.2) in patients with steadily declining serum β- hCG levels compared to 106.7 hours (±SD 72.0) in patients with primarily plateauing β-hCG levels in the declining phase. However, these differences were not significant (p>0.05).
Conclusion: We identified a median follow-up of 19 days until serum β hCG clearance in women with tubal ectopic pregnancy and successful expectant management. Although non- significant, women with initially plateauing serum β hCG showed a longer follow-up time until clearance compared to women with steadily declining β hCG levels. This information may serve as a guideline enabling clinicians to predict the length of follow-up for women with tubal ectopic pregnancy and expectant management.
Conflict of interest statement
Figures




Similar articles
-
β-hCG resolution times during expectant management of tubal ectopic pregnancies.BMC Womens Health. 2015 May 21;15:43. doi: 10.1186/s12905-015-0200-7. BMC Womens Health. 2015. PMID: 25994203 Free PMC article.
-
Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis.Ultrasound Obstet Gynecol. 2004 Jun;23(6):552-6. doi: 10.1002/uog.1061. Ultrasound Obstet Gynecol. 2004. PMID: 15170794
-
Single-dose systemic methotrexate vs expectant management for treatment of tubal ectopic pregnancy: a placebo-controlled randomized trial.Ultrasound Obstet Gynecol. 2017 Feb;49(2):171-176. doi: 10.1002/uog.17329. Epub 2017 Jan 6. Ultrasound Obstet Gynecol. 2017. PMID: 27731538 Clinical Trial.
-
Methotrexate vs placebo in early tubal ectopic pregnancy: a multi- centre double-blind randomised trial.Rev Recent Clin Trials. 2012 Aug;7(3):238-43. doi: 10.2174/157488712802281321. Rev Recent Clin Trials. 2012. PMID: 22540910 Review.
-
The Utility of Monitoring Beta-Human Chorionic Gonadotropin Levels in an Ectopic Pregnancy.Cureus. 2023 Jan 22;15(1):e34063. doi: 10.7759/cureus.34063. eCollection 2023 Jan. Cureus. 2023. PMID: 36699108 Free PMC article. Review.
Cited by
-
Expectant management versus systemic methotrexate in the management of persistent pregnancy of unknown location, a seven-year retrospective analysis.Arch Gynecol Obstet. 2024 Mar;309(3):1035-1041. doi: 10.1007/s00404-023-07332-x. Epub 2024 Jan 9. Arch Gynecol Obstet. 2024. PMID: 38194091
-
Efficacy and safety of expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.Hum Reprod Open. 2020 Oct 25;2020(4):hoaa044. doi: 10.1093/hropen/hoaa044. eCollection 2020. Hum Reprod Open. 2020. PMID: 33134560 Free PMC article. Review.
-
Effect of an Active vs Expectant Management Strategy on Successful Resolution of Pregnancy Among Patients With a Persisting Pregnancy of Unknown Location: The ACT or NOT Randomized Clinical Trial.JAMA. 2021 Aug 3;326(5):390-400. doi: 10.1001/jama.2021.10767. JAMA. 2021. PMID: 34342619 Free PMC article. Clinical Trial.
-
Unexpected rupture of an expectantly managed tubal ectopic pregnancy: a reminder for enhanced diligence.BMJ Case Rep. 2019 Dec 29;12(12):e230876. doi: 10.1136/bcr-2019-230876. BMJ Case Rep. 2019. PMID: 31888919 Free PMC article.
-
Clinical Application for Screening Down's Syndrome by Using Carboxylated Graphene Oxide-Based Surface Plasmon Resonance Aptasensors.Int J Nanomedicine. 2020 Oct 22;15:8131-8149. doi: 10.2147/IJN.S270938. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33144830 Free PMC article.
References
-
- Lund J (1955) Early ectopic pregnancy; comments on conservative treatment. J Obstet Gynaecol Br Emp 62: 70–76. - PubMed
-
- Elson J, Tailor A, Banerjee S, Salim R, Hillaby K, et al. (2004) Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis. Ultrasound Obstet Gynecol 23: 552–556. - PubMed
-
- Strobelt N, Mariani E, Ferrari L, Trio D, Tiezzi A, et al. (2000) Fertility after ectopic pregnancy. Effects of surgery and expectant management. J Reprod Med 45: 803–807. - PubMed
-
- Fernandez H, Rainhorn JD, Papiernik E, Bellet D, Frydman R (1988) Spontaneous resolution of ectopic pregnancy. Obstet Gynecol 71: 171–174. - PubMed
-
- Fernandez H, Lelaidier C, Baton C, Bourget P, Frydman R (1991) Return of reproductive performance after expectant management and local treatment for ectopic pregnancy. Hum Reprod 6: 1474–1477. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical